← FDA Drug Approvals (Drugs@FDA)
NAPROXEN SODIUM
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CATALENT · Approved 2019-01-04
Drug application
- FDA Application #
ANDA202807- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- NAPROXEN SODIUM
- Generic name
- NAPROXEN SODIUM
- Active ingredients
- NAPROXEN SODIUM
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Over-the-counter
- Sponsor
- CATALENT
- Manufacturer
- P & L Development, LLC
- First approval
- 2019-01-04
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown